BCL2L11 and Miyoshi myopathy: Additionally, low levels of Bim expression were associated with bortezomib resistance in bortezomib-resistant U266PS-R cells and primary MM cells, whereas ABT-737, a Bcl-2 homology 3 (BH3) mimetic, overcame the bortezomib resistance in U266PS-R cells [68].